595 related articles for article (PubMed ID: 17141322)
1. Retinal endovascular lysis in ischemic central retinal vein occlusion: one-year results of a pilot study.
Feltgen N; Junker B; Agostini H; Hansen LL
Ophthalmology; 2007 Apr; 114(4):716-23. PubMed ID: 17141322
[TBL] [Abstract][Full Text] [Related]
2. Retinal endovascular lysis.
Weiss JN
Ophthalmology; 2008 Jan; 115(1):216-7; author reply 218. PubMed ID: 18166422
[No Abstract] [Full Text] [Related]
3. Retinal vein occlusion and low-dose fibrinolytic therapy (R.O.L.F.): a prospective, randomized, controlled multicenter study of low-dose recombinant tissue plasminogen activator versus hemodilution in retinal vein occlusion.
Hattenbach LO; Friedrich Arndt C; Lerche R; Scharrer I; Baatz H; Margaron F; Richard G; Behrens-Baumann W; Ohrloff C
Retina; 2009; 29(7):932-40. PubMed ID: 19584651
[TBL] [Abstract][Full Text] [Related]
4. Early treatment of severe cystoid macular edema in central retinal vein occlusion with posterior sub-tenon triamcinolone acetonide.
Lin JM; Chiu YT; Hung PT; Tsai YY
Retina; 2007 Feb; 27(2):180-9. PubMed ID: 17290200
[TBL] [Abstract][Full Text] [Related]
5. The Central Retinal Vein Bypass Study: a trial of laser-induced chorioretinal venous anastomosis for central retinal vein occlusion.
McAllister IL; Gillies ME; Smithies LA; Rochtchina E; Harper CA; Daniell MD; Constable IJ; Mitchell P
Ophthalmology; 2010 May; 117(5):954-65. PubMed ID: 20163872
[TBL] [Abstract][Full Text] [Related]
6. [Radial optic neurotomy for ischemic central retinal vein occlusion].
Lommatzsch A; Heimes B; Gutfleisch M; Spital G; Trieschmann M; Pauleikhoff D
Klin Monbl Augenheilkd; 2007 Oct; 224(10):763-9. PubMed ID: 17952819
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of visual prognosis and correlative factors in retinal vein occlusion].
Zhang H; Xia Y
Zhonghua Yan Ke Za Zhi; 2002 Feb; 38(2):98-102. PubMed ID: 11955310
[TBL] [Abstract][Full Text] [Related]
8. Comparison of surgical treatments for central retinal vein occlusion; RON vs. cannulation of tissue plasminogen activator into the retinal vein.
Yamamoto T; Kamei M; Sakaguchi H; Oshima Y; Ikuno Y; Gomi F; Ohji M; Tano Y
Retina; 2009 Sep; 29(8):1167-74. PubMed ID: 19734765
[TBL] [Abstract][Full Text] [Related]
9. Short-term results of endovascular surgery with tissue plasminogen activator injection for central retinal vein occlusion.
Ishida M; Abe S; Nakagawa T; Hayashi A
Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2135-2140. PubMed ID: 28803326
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal tissue plasminogen activator for acute central retinal vein occlusion.
Lahey JM; Fong DS; Kearney J
Ophthalmic Surg Lasers; 1999 Jun; 30(6):427-34. PubMed ID: 10392729
[TBL] [Abstract][Full Text] [Related]
11. Updated cannulation technique for tissue plasminogen activator injection into peripapillary retinal vein for central retinal vein occlusion.
van Overdam KA; Missotten T; Spielberg LH
Acta Ophthalmol; 2015 Dec; 93(8):739-44. PubMed ID: 26310993
[TBL] [Abstract][Full Text] [Related]
12. Surgical chorioretinal venous anastomosis for ischemic central retinal vein occlusion.
Peyman GA; Kishore K; Conway MD
Ophthalmic Surg Lasers; 1999; 30(8):605-14. PubMed ID: 10507562
[TBL] [Abstract][Full Text] [Related]
13. Prospective study of intravitreal ranibizumab as a treatment for decreased visual acuity secondary to central retinal vein occlusion.
Spaide RF; Chang LK; Klancnik JM; Yannuzzi LA; Sorenson J; Slakter JS; Freund KB; Klein R
Am J Ophthalmol; 2009 Feb; 147(2):298-306. PubMed ID: 18929354
[TBL] [Abstract][Full Text] [Related]
14. Fluocinolone acetonide sustained drug delivery device for chronic central retinal vein occlusion: 12-month results.
Ramchandran RS; Fekrat S; Stinnett SS; Jaffe GJ
Am J Ophthalmol; 2008 Aug; 146(2):285-291. PubMed ID: 18533125
[TBL] [Abstract][Full Text] [Related]
15. Subretinal recombinant tissue plasminogen activator injection and pneumatic displacement of thick submacular hemorrhage in Age-Related macular degeneration.
Olivier S; Chow DR; Packo KH; MacCumber MW; Awh CC
Ophthalmology; 2004 Jun; 111(6):1201-8. PubMed ID: 15177972
[TBL] [Abstract][Full Text] [Related]
16. Retinal vein cannulation with prolonged infusion of tissue plasminogen activator (t-PA) for the treatment of experimental retinal vein occlusion in dogs.
Tameesh MK; Lakhanpal RR; Fujii GY; Javaheri M; Shelley TH; D'Anna S; Barnes AC; Margalit E; Farah M; De Juan E; Humayun MS
Am J Ophthalmol; 2004 Nov; 138(5):829-39. PubMed ID: 15531319
[TBL] [Abstract][Full Text] [Related]
17. Retinal surgery for treatment of central retinal vein occlusion.
Weiss JN
Ophthalmic Surg Lasers; 2000; 31(2):162-5. PubMed ID: 10743932
[TBL] [Abstract][Full Text] [Related]
18. Vitrectomy with complete posterior hyaloid removal for ischemic central retinal vein occlusion: series of cases.
Leizaola-Fernández C; Suárez-Tatá L; Quiroz-Mercado H; Colina-Luquez J; Fromow-Guerra J; Jiménez-Sierra JM; Guerrero-Naranjo JL; Morales-Cantón V
BMC Ophthalmol; 2005 May; 5():10. PubMed ID: 15943889
[TBL] [Abstract][Full Text] [Related]
19. Retinal endovascular surgery for central retinal vein occlusion: initial experience of four surgeons.
Bynoe LA; Hutchins RK; Lazarus HS; Friedberg MA
Retina; 2005; 25(5):625-32. PubMed ID: 16077361
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcomes of vitrectomy with or without arteriovenous sheathotomy in branch retinal vein occlusion.
Kumagai K; Furukawa M; Ogino N; Uemura A; Larson E
Retina; 2007 Jan; 27(1):49-54. PubMed ID: 17218915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
